DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tamibarotene
Tamibarotene
WO 2017/177167 Al 12 October 2017 (12.10.2017) P O P C T
Preparation and Antitumor Activity of a Tamibarotene-Furoxan Derivative
Research in Your Backyard Developing Cures, Creating Jobs
TITLE: Phase I/II Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
Incidence of Differentiation Syndrome Associated with Treatment
WO 2013/061161 A2 2 May 2013 (02.05.2013) P O P C T
Leukemia I N S I G H T S VOL
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Editorial Retinoids Induced Cancer Stem Cell Differentiation And
Tamibarotene in Patients with Acute Promyelocytic Leukaemia Relapsing After Treatment with All-Trans Retinoic Acid and Arsenic Trioxide D
Multiple Isolated Extramedullary Relapse of Acute Promyelocytic
Gene Signature of Children with Severe Respiratory Syncytial Virus Infection
Public Summary of Opinion on Orphan Designation Tamibarotene for the Treatment of Acute Promyelocytic Leukaemia
Antigen Binding Protein and Its Use As Addressing Product for the Treatment of Cancer
Cooperative Therapeutic Action of Retinoic Acid Receptor and Retinoid X Receptor Agonists in a Mouse Model of Alzheimer’S Disease
Stembook 2018.Pdf
Discovery of SARS-Cov-2 Antiviral Drugs Through Large-Scale Compound Repurposing
HHS Public Access Author Manuscript
Top View
Small-Cap Research
[email protected]
The Role of the Retinoids in Schizophrenia: Genomic and Clinical Perspectives
Old Drugs As New Treatments for Neurodegenerative Diseases
Cytrx Corporation (Exact Name of Registrant As Specified in Its Charter)
Acute Promyelocytic Leukemia Facts
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
WO 2017/091762 Al O
Draft COMP Agenda 6-8 November 2018
Vitamin a and Its Derivatives- Retinoic Acid and Retinoid Pharmacology
Vitamin A, Retinoic Acid And
2020 Medicines in Development ꟷ Cancer
The Acute Myeloid Leukaemia Market
Long Term Follow up of Patients with Advanced Cancers After Chemotherapy and Traditional Medicine (82 Cases) George Zhu
A Large-Scale Drug Repositioning Survey for SARS-Cov-2 Antivirals
Appendix a Study Protocol for the Study: “Clinical
Clinical Prolonged Follow up of Patients With
Annexes to the Annual Report of the European Medicines Agency 2018
Molecular Blueprints for Antitumor Drugs
| Hao Wanatha Maria De Entrala Maalum
Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
Relationship Between the Effects of Food on the Pharmacokinetics Of
Acute Promyelocytic Leukemia Current Treatment Algorithms ✉ Musa Yilmaz 1, Hagop Kantarjian 1 and Farhad Ravandi 1
WO 2U11/132171 Al
Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Aβ42 Aggregation in Alzheimer’S Disease
Oncology Drugs in the Pipeline
Anticancer Drugs Repurposed for Alzheimer's Disease: a Systematic
COMP Agenda of the 8-10 December 2015 Meeting
Download Product Insert (PDF)
Trifarotene: a Current Review and Perspectives in Dermatology
Availability of the Drugs for Malignant Diseases Treatment: Comparison Between Developing and Developed Countries
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
Medicines & Vaccines in Development for Cancer
Tamibarotene As Maintenance Therapy for Acute
Endogenous and Combination Retinoids Are Active In
Highlighting the Gaps in Hazard and Risk Assessment of Unregulated
Tamibarotene: a Candidate Retinoid Drug for Alzheimer's Disease
The Retinoic Acid Receptor (RAR) Α-Specific Agonist Am80
And Chronic Myelomonocytic Leukemia (CMML)
Recurrent RARB Translocations in Acute
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016
Retinoid Signals and Th17 Mediated Pathology